Sample size tables for exact single‐stage phase II designs

• Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα

  2025 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access

  5

  citations
• UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial

  2025 Med article Medicine Head and Neck Cancer Studies Open access

  7

  citations
• Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study

  2025 Clinical Cancer Research article Medicine Ovarian cancer diagnosis and treatment Open access

  14

  citations
• UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

  2024 medRxiv preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  1

  citations
• New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas

  2022 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent

  14

  citations
• Single fiber reflectance spectroscopy for pancreatic cancer detection during endoscopic ultrasound guided fine needle biopsy: a prospective cohort study

  2022 International Journal of Medical Sciences article Medicine Optical Imaging and Spectroscopy Techniques Open access

  8

  citations
• Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”

  2021 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access

  16

  citations
• Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

  2020 BMJ Open article Medicine Cancer Immunotherapy and Biomarkers Open access

  11

  citations
• Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

  2020 European Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment

  72

  citations

9 results